Dr. Mark Hoeprich, MD
Claim this profileKettering Health
Studies Glioblastoma
Studies Brain Tumor
4 reported clinical trials
10 drugs studied
Area of expertise
1Glioblastoma
IDH positive
IDH negative
MET negative
2Brain Tumor
Stage IV
Affiliated Hospitals
Clinical Trials Mark Hoeprich, MD is currently running
SB-01 Injection
for Degenerative Disc Disease
The purpose of the study is to confirm the safety and effectiveness of SB-01 For Injection in adult patients with chronic low back pain and related disability due to Lumbar Degenerative Disc Disease. The primary effectiveness hypothesis is superiority of the investigational product relative to control in terms of the percentage of subjects improving in pain-related disability.
Recruiting1 award Phase 323 criteria
GammaTile + Stupp Protocol
for Glioblastoma
This trial tests if adding GammaTile radiation therapy to standard treatment can improve outcomes for patients with newly diagnosed GBM. GammaTile delivers quick, direct radiation to the tumor, which may help control the tumor better and improve survival rates.
Recruiting3 awards Phase 46 criteria
More about Mark Hoeprich, MD
Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Mark Hoeprich, MD has experience with
- GammaTile Radiation Therapy Implantation
- Temozolamide
- Surgical Tumor Resection
- EBRT
- GammaTile
- SB-01 For Injection
Breakdown of trials Mark Hoeprich, MD has run
Glioblastoma
Brain Tumor
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark Hoeprich, MD specialize in?
Mark Hoeprich, MD focuses on Glioblastoma and Brain Tumor. In particular, much of their work with Glioblastoma has involved IDH positive patients, or patients who are IDH negative.
Is Mark Hoeprich, MD currently recruiting for clinical trials?
Yes, Mark Hoeprich, MD is currently recruiting for 3 clinical trials in Kettering Ohio. If you're interested in participating, you should apply.
Are there any treatments that Mark Hoeprich, MD has studied deeply?
Yes, Mark Hoeprich, MD has studied treatments such as GammaTile radiation therapy implantation, Temozolamide, Surgical tumor resection.
What is the best way to schedule an appointment with Mark Hoeprich, MD?
Apply for one of the trials that Mark Hoeprich, MD is conducting.
What is the office address of Mark Hoeprich, MD?
The office of Mark Hoeprich, MD is located at: Kettering Health, Kettering, Ohio 45429 United States. This is the address for their practice at the Kettering Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.